This compound, with CAS number 376608-75-2, is a complex nucleoside analogue derivative. Its structure features a modified ribose sugar moiety (protected as a cyclopentane-1,3-dioxolane) linked to a 7-chloro-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidine base. The presence of the 2-hydroxyethoxy side chain on the sugar ring is a characteristic modification. Extensive patent and literature research identifies this molecule as a key synthetic intermediate in the production of Remdesivir (GS-5734), a broad-spectrum antiviral nucleotide prodrug. It represents a crucial advanced building block in the multi-step synthesis of this important active pharmaceutical ingredient (API). The specific stereochemistry ((3aR,4S,6R,6aS)) and the functional groups are essential for the final biological activity of the drug. As a high-value, specialized intermediate, its primary industrial use is confined to the pharmaceutical synthesis pathway for Remdesivir. It is not a general-purpose synthetic reagent. Handling requires standard precautions for potent biochemical intermediates in a controlled laboratory or manufacturing environment.